Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 49: 845-846, 2003; 10.1373/49.6.845
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McIntosh, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McIntosh, K.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Evidence Based Laboratory Medicine and Test Utilization
(Clinical Chemistry. 2003;49:845-846.)
© 2003 American Association for Clinical Chemistry, Inc.


Editorial

The SARS Coronavirus: Rapid Diagnostics in the Limelight

Kenneth McIntosh1

1 Emeritus Chief, Division of Infectious Disease, and, Professor of Pediatrics, Children’s Hospital, Harvard Medical School, Boston, MA 02115

The first 20% of the full text of this article appears below.

As the severe acute respiratory syndrome (SARS) epidemic spreads, specific, rapid, and practical diagnostic tests will become increasingly critical, both for the control of the epidemic and for the management of patients. At present, outside East and Southeast Asia diagnosis depends on a clinical case definition that includes travel to, or exposure to sick contacts who have traveled to, specific parts of the world (1). As the epidemic matures, however, such epidemiologic connections will be increasingly difficult to demonstrate, and a clinical case definition that depends on this information will become increasingly irrelevant. In East and Southeast Asia, the rapidly expanding epidemic makes specific viral diagnosis even more essential. In such an evolving situation, the report by Poon et al. from Hong Kong (2), in combination with the published diagnostic technologies of that group and others in Europe and the United States (3)(4)(5), takes on extraordinary importance. Moreover, the development and publication of a rapid test for the SARS coronavirus in clinical samples, just weeks after the first reports of the emergence of the disease (6) is extraordinary.

As a historical footnote, this technologic tour de force is in extreme contrast to the diagnostic tests that led to the first descriptions of coronaviruses over 35 years ago. At that time, the most . . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
J. Clin. Microbiol.Home page
M. Inoue, T. Barkham, L. K. Keong, L. S. Gee, and H. Wanjin
Performance of Single-Step Gel-Based Reverse Transcription-PCR (RT-PCR) Assays Equivalent to That of Real-Time RT-PCR Assays for Detection of the Severe Acute Respiratory Syndrome-Associated Coronavirus
J. Clin. Microbiol., August 1, 2005; 43(8): 4262 - 4265.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Association for Clinical Chemistry.